October 23, 2021

Ultivue announces two new independent board members

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ultivue announces the addition of two independent board members, Fenel Eloi and Mary Pat Lancelotta, to help strengthen its position as a leader in […]
October 23, 2021

Ultivue raises $50M in series D funding

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ultivue, a leader in advancing precision medicine solutions through a unique approach that combines multiplex biomarker analysis with same slide traditional H&E for tissue […]
October 23, 2021

Ultivue announces new executive team member

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ultivue announces the addition of Richard C. Malabre, CPA in the role of Chief Financial Officer, as the company adds to its growing executive […]
February 18, 2021

Ultivue announces new executive team members in Research and Corporate Development

CAMBRIDGE, MA – Ultivue announces the addition of new executive team members in order to help strengthen its position as a leading assay development solutions provider […]
February 12, 2021

Ultivue to Participate in Cowen’s 41st Annual Health Care Conference

CAMBRIDGE, Mass.–Ultivue, an industry leader in multiplexing for tissue biomarker analysis, will participate in Cowen’s 41st Annual Health Care Conference, a virtual event taking place March 1-4, […]
April 9, 2020

A Message To Our Community About COVID-19

April 9, 2020 Our hearts and thoughts go out to all those impacted by COVID-19. This is an unprecedented situation and we are all working to […]
December 27, 2019

Ultivue expands UltiMapper™ portfolio of multiplex marker assays for comprehensive phenotyping of the immune microenvironment and tissue immuno-profiling research

CAMBRIDGE, Mass, November 6, 2019 – Ultivue, a leading developer of tissue biomarker identification and quantification assays for translational research and pathology labs, today announced the expansion of its UltiMapper™ multiplex immunofluorescence kit portfolio with a T-reg and MDSC kit.
December 27, 2019

Ultivue Raises $22 Million in Series C Funding

CAMBRIDGE, Mass, June 27, 2019 – Ultivue, the innovation leader in tissue biomarker identification and quantification assays for translational and pathology research labs, today announced the […]
December 27, 2019

Ultivue releases breakthrough innovations for multiplex IHC: 16-marker whole-slide visualization and high marker co-localization in FFPE tissue

CAMBRIDGE, Mass, March 28, 2018 – Ultivue today unveiled the expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology through comprehensive visualization of a whole […]
December 27, 2019

Ultivue Expands Global Presence with Opening of European Subsidiary, Ultivue EMEA Srl

CAMBRIDGE, Mass, February 21, 2019 – Ultivue, a developer of tissue biomarker identification and quantification assays for pathology and translational research labs, today announced that it […]
Contact Us